Literature DB >> 19238675

K-ras mutations and cetuximab in colorectal cancer.

Maher Albitar, Chenhsiung Yeh, Wanlong Ma.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19238675

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  3 in total

Review 1.  Concordance of predictive markers for EGFR inhibitors in primary tumors and metastases in colorectal cancer: a review.

Authors:  Jara M Baas; Lisanne L Krens; Henk-Jan Guchelaar; Hans Morreau; Hans Gelderblom
Journal:  Oncologist       Date:  2011-07-08

Review 2.  Predictive and prognostic markers in colorectal cancer.

Authors:  Ben George; Scott Kopetz
Journal:  Curr Oncol Rep       Date:  2011-06       Impact factor: 5.075

3.  Beyond KRAS: perspectives on new potential markers of intrinsic and acquired resistance to epidermal growth factor receptor inhibitors in metastatic colorectal cancer.

Authors:  Fotios Loupakis; Chiara Cremolini; Gabriella Fontanini; Irene Stasi; Lisa Salvatore; Alfredo Falcone
Journal:  Ther Adv Med Oncol       Date:  2009-11       Impact factor: 8.168
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.